SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-015753
Filing Date
2024-02-21
Accepted
2024-02-21 16:06:09
Documents
14
Period of Report
2024-02-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ea0200428-8k_unicyc.htm   iXBRL 8-K 23674
  Complete submission text file 0001213900-24-015753.txt   198895

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE uncy-20240221.xsd EX-101.SCH 3063
3 XBRL LABEL FILE uncy-20240221_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE uncy-20240221_pre.xml EX-101.PRE 22391
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0200428-8k_unicyc_htm.xml XML 3716
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40582 | Film No.: 24659399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)